Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience

Surg Today. 2023 Oct;53(10):1181-1187. doi: 10.1007/s00595-023-02731-8. Epub 2023 Aug 22.

Abstract

Purpose: Soft tissue sarcomas are rare malignant tumors. Liposarcoma constitutes the most frequent histological subtype of retroperitoneal sarcoma. The prognosis of soft tissue sarcomas depends on clinical and histologic characteristics.

Objective: Evaluate variables that may be related to the overall and local recurrence-free survival in patients with retroperitoneal liposarcoma and discuss the need for visceral resection en-bloc for tumors.

Methods: A retrospective analysis was conducted of the medical records of 60 patients seen between 1997 and 2017 who underwent surgical resection of retroperitoneal liposarcoma.

Results: The overall survival rate at 5 years of follow-up was 75.22% (95% confidence interval [CI] 0.58-0.86). The probability of a local recurrence-free survival at 5 years of follow-up was 26.04% (95% CI 0.11-0.44). The multivariate analysis showed that dedifferentiated or pleomorphic tumors and R2/fragmented resection were associated with a shorter time to recurrence. No other characteristics markedly influenced the overall survival (P > 0.05).

Conclusion: Patients with dedifferentiated or pleomorphic tumors and incomplete resection were associated with higher local recurrence rates than others. This study reinforces the need for complete and en-bloc resection with organs when there is clear involvement or technical surgical difficulty to maintain the tumor integrity.

Keywords: Liposarcoma; Retroperitoneal space; Retrospective study; Surgical oncology; Survival analysis.

MeSH terms

  • Humans
  • Liposarcoma* / pathology
  • Liposarcoma* / surgery
  • Neoplasm Recurrence, Local
  • Prognosis
  • Retroperitoneal Neoplasms* / surgery
  • Retrospective Studies
  • Sarcoma* / pathology
  • Sarcoma* / surgery
  • Survival Rate

Supplementary concepts

  • Retroperitoneal liposarcoma